share_log

Rapport Therapeutics | SC 13G: Statement of acquisition of beneficial ownership by individuals-ARCH Venture Fund XII, L.P.(10.2%),ARCH Venture Partners XII, L.P.(10.2%), etc.

Rapport Therapeutics | SC 13G:超过5%持股股东披露文件-ARCH Venture Fund XII, L.P.(10.2%),ARCH Venture Partners XII, L.P.(10.2%)等

美股SEC公告 ·  11/15 06:17
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息